Autologous Platelet Enriched Gel Versus Metalloproteinase Inhibitor in the Healing of Chronic Lower Leg Ulcers

N/ACompletedNCT00658983

University Hospital, Ghent18 enrolled

Overview

Compare Autologous Platelet Enriched Gel versus Metalloproteinase Inhibitor in the healing of chronic lower leg ulcers.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Chronic Lower Leg Ulcer

Interventions

Autologous Platelet Enriched GelOTHER

Treatment with Autologous Platelet Enriched Gel

Metalloproteinase InhibitorOTHER

Treatment with Metalloproteinase Inhibitor (Promogran)

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 year or older * A non-healing chronic lower leg ulcer * Platelet ranges of 150000 per ml circulating blood Exclusion Criteria: * Presence of a tumor or metastatic disease * Hypersensitive to collagen regenerated cellulose * Hemodynamic unstable patient * Hypercoagulability * Heart decompensation or angina pectoris

Locations (1)

University Hospital Ghent

Ghent, Belgium

Outcomes

Primary Outcomes

Wound healing

Time frame: 6 weeks

Secondary Outcomes

Wound healing

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.